FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205679173> ?p ?o ?g. }

• W3205679173 endingPage "164" @default.
• W3205679173 startingPage "153" @default.
• W3205679173 abstract "Long-term use of nucleotide analogs such as adefovir (ADV) or tenofovir disoproxil fumarate (TDF) may cause renal impairment. Tenofovir alafenamide (TAF) has less systemic exposure than TDF did. The aims were to examine longitudinal changes in renal function and biochemical parameters for 2 years after switching from long-term ADV and TDF to TAF, and to explore factors associated with improved renal function after TAF in patients with chronic hepatitis B.The prospective observational cohort study included 306 patients with chronic hepatitis B who underwent switching from long-term TDF or ADV to TAF. The primary outcome was the changes in estimated glomerular filtration rate (eGFR) after TAF.Among 306 patients, 190 (65.3%) and 106 (34.7%) had chronic kidney disease (CKD) stages 1-2 and 3a-4 at baseline. In patients with CKD stages 3a-4, the mean eGFR significantly increased until week 12 and plateaued from week 12 to year 2 (adjusted slope using linear mixed effect models: +9.01 ml/min/1.73 m2 /year until week 12; p < 0.001). In contrast, the mean eGFR plateaued from baseline to year 2 in the CKD stages 1-2 subgroup. Multivariate logistic regression showed that baseline CKD stage ≥3a, steeper decline in eGFR 1 year before TAF, and shorter duration of any nucleotide analog use was significantly associated with ≥10% improvement in eGFR in year 1.Switching from TDF or ADV to TAF resulted in favorable renal safety for 2 years. In CKD stage 3a-4 subgroup, eGFR after TAF was recovered in the first 12 weeks and subsequently stabilized." @default.
• W3205679173 created "2021-10-25" @default.
• W3205679173 creator A5010056452 @default.
• W3205679173 creator A5014470642 @default.
• W3205679173 creator A5015577892 @default.
• W3205679173 creator A5024325916 @default.
• W3205679173 creator A5026182073 @default.
• W3205679173 creator A5031710130 @default.
• W3205679173 creator A5044932403 @default.
• W3205679173 creator A5053329267 @default.
• W3205679173 creator A5057057637 @default.
• W3205679173 creator A5066429603 @default.
• W3205679173 creator A5071497400 @default.
• W3205679173 creator A5084522512 @default.
• W3205679173 creator A5089243471 @default.
• W3205679173 date "2021-11-06" @default.
• W3205679173 modified "2023-10-15" @default.
• W3205679173 title "Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B" @default.
• W3205679173 cites W1950368524 @default.
• W3205679173 cites W1975047879 @default.
• W3205679173 cites W1999664635 @default.
• W3205679173 cites W2021553032 @default.
• W3205679173 cites W2065143046 @default.
• W3205679173 cites W2065341870 @default.
• W3205679173 cites W2111495377 @default.
• W3205679173 cites W2196190612 @default.
• W3205679173 cites W2402419524 @default.
• W3205679173 cites W2467227824 @default.
• W3205679173 cites W2551687229 @default.
• W3205679173 cites W2604211538 @default.
• W3205679173 cites W2605785536 @default.
• W3205679173 cites W2736144485 @default.
• W3205679173 cites W2782856081 @default.
• W3205679173 cites W2791839818 @default.
• W3205679173 cites W2883185952 @default.
• W3205679173 cites W2891971495 @default.
• W3205679173 cites W2906318256 @default.
• W3205679173 cites W2954928220 @default.
• W3205679173 cites W3007144859 @default.
• W3205679173 cites W3043529563 @default.
• W3205679173 cites W3133931156 @default.
• W3205679173 cites W3139194731 @default.
• W3205679173 cites W4211170672 @default.
• W3205679173 doi "https://doi.org/10.1111/hepr.13726" @default.
• W3205679173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34687121" @default.
• W3205679173 hasPublicationYear "2021" @default.
• W3205679173 type Work @default.
• W3205679173 sameAs 3205679173 @default.
• W3205679173 citedByCount "1" @default.
• W3205679173 countsByYear W32056791732023 @default.
• W3205679173 crossrefType "journal-article" @default.
• W3205679173 hasAuthorship W3205679173A5010056452 @default.
• W3205679173 hasAuthorship W3205679173A5014470642 @default.
• W3205679173 hasAuthorship W3205679173A5015577892 @default.
• W3205679173 hasAuthorship W3205679173A5024325916 @default.
• W3205679173 hasAuthorship W3205679173A5026182073 @default.
• W3205679173 hasAuthorship W3205679173A5031710130 @default.
• W3205679173 hasAuthorship W3205679173A5044932403 @default.
• W3205679173 hasAuthorship W3205679173A5053329267 @default.
• W3205679173 hasAuthorship W3205679173A5057057637 @default.
• W3205679173 hasAuthorship W3205679173A5066429603 @default.
• W3205679173 hasAuthorship W3205679173A5071497400 @default.
• W3205679173 hasAuthorship W3205679173A5084522512 @default.
• W3205679173 hasAuthorship W3205679173A5089243471 @default.
• W3205679173 hasConcept C126322002 @default.
• W3205679173 hasConcept C126894567 @default.
• W3205679173 hasConcept C142462285 @default.
• W3205679173 hasConcept C159641895 @default.
• W3205679173 hasConcept C188816634 @default.
• W3205679173 hasConcept C203014093 @default.
• W3205679173 hasConcept C2522874641 @default.
• W3205679173 hasConcept C2776175608 @default.
• W3205679173 hasConcept C2777382497 @default.
• W3205679173 hasConcept C2777869810 @default.
• W3205679173 hasConcept C2778653478 @default.
• W3205679173 hasConcept C2779517838 @default.
• W3205679173 hasConcept C2911190787 @default.
• W3205679173 hasConcept C2993143319 @default.
• W3205679173 hasConcept C3013748606 @default.
• W3205679173 hasConcept C3020491458 @default.
• W3205679173 hasConcept C71924100 @default.
• W3205679173 hasConcept C90924648 @default.
• W3205679173 hasConceptScore W3205679173C126322002 @default.
• W3205679173 hasConceptScore W3205679173C126894567 @default.
• W3205679173 hasConceptScore W3205679173C142462285 @default.
• W3205679173 hasConceptScore W3205679173C159641895 @default.
• W3205679173 hasConceptScore W3205679173C188816634 @default.
• W3205679173 hasConceptScore W3205679173C203014093 @default.
• W3205679173 hasConceptScore W3205679173C2522874641 @default.
• W3205679173 hasConceptScore W3205679173C2776175608 @default.
• W3205679173 hasConceptScore W3205679173C2777382497 @default.
• W3205679173 hasConceptScore W3205679173C2777869810 @default.
• W3205679173 hasConceptScore W3205679173C2778653478 @default.
• W3205679173 hasConceptScore W3205679173C2779517838 @default.
• W3205679173 hasConceptScore W3205679173C2911190787 @default.
• W3205679173 hasConceptScore W3205679173C2993143319 @default.
• W3205679173 hasConceptScore W3205679173C3013748606 @default.
• W3205679173 hasConceptScore W3205679173C3020491458 @default.

• next